CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale President, COO & GM China sold 10,000 shares at an average $358.27 ($3,582,663)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $372.78 ($559,163)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Agreement ended · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 2,543,800 shares at $2.85 ($7,249,830)
- 4 Open-market sale CMO, Hematology sold 6,000 shares at an average $397.96 ($2,387,774)
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 411,838 shares at an average $82.04 ($33,788,320)
- 4 Open-market sale CMO, Hematology sold 12,901 shares at an average $358.14 ($4,620,390)
- 8-K Event Other events
- 4 Open-market buy 10% owner bought 165,529 shares at $302.06 ($49,999,938)
- 4 Open-market sale Chief Executive Officer sold 288,639 shares at an average $109.77 ($31,685,324)
- 4 Open-market sale CMO, Hematology sold 1,087 shares at an average $318.88 ($346,621)
- 8-K Event Other events
Page 33 of 64 · 1,278 filings